Gastric lymphoma - epidemiology, clinical manifestations and current therapy management
Open Access
- 25 August 2023
- journal article
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 46 (1) , 283-296
Abstract
Gastric lymphoma is a rare malignant disease, which in recent years has been showing an increasing incidence in the population. The development of MALT is most often the result of chronic Helicobacter pylori infection. Further chronic inflammation may result in malignant transformation of MALT to high-grade diffuse large B-cell lymphoma (DLBCL). However, DLBCL lymphomas most often arise de novo. The risk of primary gastric lymphoma increases with age. The symptoms of gastric lymphoma are very diverse and non-specific, which is why the knowledge about this disease and the differential diagnosis of diseases with similar symptoms play a very important role. The gold standard for diagnosing gastric lymphomas is upper GI endoscopy with biopsy, and sometimes additional imaging tests are necessary to make a proper diagnosis. It is very important to start treatment quickly - the first-line treatment is the eradication of Helicobacter pylori bacteria. Currently, we also have other therapeutic pathways that can change the course of the disease. The therapeutic plan should be individually selected for the needs of the individual patient. Changes detected in the early stages and treated quickly give patients a good chance of being cured. This publication is an attempt to summarize the current state of knowledge about the epidemiology, etiopathogenesis, clinical picture and therapeutic strategies in the case of gastric lymphoma.Keywords
This publication has 26 references indexed in Scilit:
- Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2020
- Endoscopic features and clinical outcomes of colorectal mucosa-associated lymphoid tissue lymphomaGastrointestinal Endoscopy, 2018
- Gastrointestinal lymphomas: French Intergroup clinical practice recommendations for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFH)Digestive and Liver Disease, 2018
- Clinical aspects and therapy of gastrointestinal MALT lymphomaBest Practice & Research Clinical Haematology, 2017
- Intensity Modulated Radiation Therapy for Early-Stage Primary Gastric Diffuse Large B-Cell Lymphoma: Dosimetric Analysis, Clinical Outcome, and Quality of LifeInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2016
- Effects of Helicobacter pylori Eradication on Early Stage Gastric Mucosa–Associated Lymphoid Tissue LymphomaClinical Gastroenterology and Hepatology, 2010
- Prognostic factors for primary gastrointestinal lymphomaHematological Oncology, 1995
- Primary B-cell gastric lymphoma: A clinicopathological study of 145 patientsGastroenterology, 1991
- Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literatureCancer, 1989
- Has the incidence of primary gastric lymphoma increased?Cancer, 1989